Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ANTICANCER RESEARCH 34: 4345-4350 (2014) Surgical Approach and Long-term Clinical Outcome in Women with Microinvasive Cervical Cancer FRANCESCO SOPRACORDEVOLE1, GIUSEPPE CHIOSSI2, MAGGIORINO BARBERO3, PAOLO CRISTOFORONI4, BRUNO GHIRINGHELLO5, ANTONIO FREGA6, FRANCESCA TORTOLANI2, FAUSTO BOSELLI2, NICOLÒ CLEMENTE7, ANDREA CIAVATTINI7, ITALIAN SOCIETY OF COLPOSCOPY and CERVICO-VAGINAL PATHOLOGY (SICPCV) 1Department of Gynecological Oncology, Centro di Riferimento Oncologico, Aviano, Italy; of Gynaecological, Obstetric and Pediatric Sciences, Section of Gynaecology, University of Modena and Reggio Emilia, Modena, Italy; 3Department of Obstetrics and Gynecology, Asti Community Hospital, Asti, Italy; 4Department of Obstetrics and Gynecology, University of Genoa, Genoa, Italy; 5Department of Pathology, University of Turin, Turin, Italy; 62nd Clinic of Obstetrics and Gynaecology, University "La Sapienza", Rome, Italy; 7Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy 2Department Abstract. Aim: To assess the efficacy and safety of conservative surgical approach for microinvasive cervical cancer with regards to cone margins status and lymph vascular space invasion (LVSI). Patients and Methods: This was a multicentre retrospective cohort study of 153 women diagnosed with microinvasive cervical cancer over a 10 years period (1993-2003). Results: In conservatively-treated women (n=80), neither cancer mortality nor disease relapse after 184.5±20.5 months of follow-up was detected. Residual disease in women who underwent secondary surgery was significantly related to positive margins on the primary cone excision (p=0.005) while no correlation with LVSI emerged. Conclusion: Conization can represent the definitive treatment for stage IA1, if surgical margins are cancer-free, independently of LVSI. A conservative surgical approach could also be considered in women with IA2 cervical cancer when preservation of fertility is strongly requested. A close long-term surveillance should be scheduled for conservatively-treated women In the last decades, both the relative proportion and absolute incidence of microinvasive cervical cancer have increased ten times in developed Countries, mainly in young women aged Correspondence to: Andrea Ciavattini, MD, Gynecologic Section Woman's Health Sciences Department, Polytechnic University of Marche, Via F. Corridoni 11 – 60123 Ancona, Italy. Tel: +39 07136745, Fax: +39 07136575, e-mail: [email protected] Key Words: Conization, microinvasive cervical cancer, cone margins, lymph vascular space invasion. 0250-7005/2014 $2.00+.40 less than 40 years (1). Furthermore, we have seen a continuous trend of delayed childbearing, which results in an increased proportion of women diagnosed with a cervical cancer before their first pregnancy. Even if the prognosis of microinvasive cervical cancer is favorable, as reported by several studies (2-5), this diagnosis actually represents a difficult management dilemma, specifically in young women who desire to preserve their childbearing potential. Different approaches have been employed to treat microinvasive cervical cancer, and controversies still exist on the surgical procedure that should be considered for the optimal management of the disease (6-13). Traditional surgical therapy for cervical cancer includes hysterectomy, with loss of childbearing potential. However, in the last years, a trend towards a conservative surgical approach has emerged, as preservation of fertility is desirable in young women, and radical procedures are associated with higher morbidity and mortality rates (14). Actually, both conization and simple hysterectomy are considered to be effective treatments for stage IA1 tumors. Conization is considered an acceptable management of stage IA1 cervical cancer, if the margin of the cone excision is clear and the lymph vascular space invasion (LVSI) has not occurred. If fertility preservation is desired, conization is satisfactory if all margins are clear (15). Radical hysterectomy with bilateral pelvic lymphadenectomy is the standard treatment of stage IA2 tumor. For this group of patients, a fertility preserving option is radical trachelectomy, which includes resection of the entire cervix and surrounding parametria, preceded by a laparoscopic bilateral pelvic lymphadenectomy (16). It is obvious that a close long-term surveillance should be 4345 ANTICANCER RESEARCH 34: 4345-4350 (2014) scheduled for conservatively-treated women and, in the absence of specific guidelines, a 10-year follow-up should suffice for stage IA disease (1). The aim of the present study was to describe the management and long-term outcome of women with microinvasive cervical cancer in four Gynecological Oncology Units in Northern Italy. The safety of a fertilitysparing surgical approach, with regard to prognostic factors such as the cone margins status and the LVSI was evaluated. The study was supported by the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Patients and Methods Patients and surgical approaches. This was a multicentre retrospective cohort study of 153 women diagnosed with microinvasive cervical cancer over a 10-year period (1993-2003) in four Gynecologic Oncology Units in Northern Italy. Demographic data, surgical and pathological data as well as follow-up information were acquired by medical charts review. Among demographic data, age, menopause status and parity were evaluated. Surgical data included type of conization technique (cold knife conization, laser conization and large loop excision of the transformation zone; LLETZ) and type of hysterectomy (simple or radical, abdominal or vaginal approach). Pathologic records were reviewed regarding depth of invasion, horizontal extension of the tumor and the presence of LVSI. For patients who were managed by conization, the parameters of the cone specimens included also the status of surgical margins. In patients who underwent secondary surgery, both specimens were analyzed to determine the total depth of invasion and horizontal extension. All cases were retrospectively staged according the 2009 International Federation of Gynecology and Obstetrics (FIGO) revised nomenclature: microinvasive carcinoma of the uterine cervix (FIGO stage IA) is defined as an invasive carcinoma which can be diagnosed only by microscopy, with deepest invasion ≤5 mm and largest extension ≤7 mm. Stage IA1 cervical cancer has a measured stromal invasion of ≤3 mm in depth and extension of ≤7 mm while stage IA2 cervical cancer has a measured stromal invasion of >3 mm and not >5 mm with an extension of not >7 mm (17). All patients were followed-up every 3 months for the first year, every 6 months up to the second year and yearly thereafter. Followup included pelvic examination, Pap smear and colposcopy. Disease recurrence was defined as a histological diagnosis of Cervical Intraepithelial Neoplasia of Grade 3 (CIN3) or more. Statistical analysis. Statistical analysis was performed with the MedCalc database (MedCalc Software, Ostend, Belgium), assisted by the use of the Student’s t-test, χ2 testing and the Fisher’s exact test, as appropriate for categorical or continuous variables. A pvalue <0.05 was considered statistically significant Results During the study period, a total of 153 women with microinvasive cervical cancer, according to the FIGO classification staged as IA1 and IA2, were identified. The mean age was 44±12 years (range=25-78 years); 42 women 4346 Table I. Association between primary conservative surgery and demographic and clinical variables. Hysterectomy Conservative surgery p-Value (N=21) (N=132) Age at diagnosis <45 years old ≥45 years old Year of diagnosis 1993-1997 1998-2003 Tumor stage IA1 IA2 0.001 4 (19%) 17 (81%) 79 (59.8%) 53 (40.2%) 16 (76.2%) 5 (23.8%) 53 (40.2%) 79 (59.8%) 20 (95.2%) 1 (4.8%) 123 (93.2%) 9 (6.8%) 0.004 0.9 (27.5%) were menopausal and 83 (54.2%) were <45 years old. Mean parity was 1.3±1.4. Diagnosis of microinvasive cervical carcinoma was made on tissue sample obtained with cervical conization in 132 cases; the remaining 21 cases were diagnosed after a non-conservative surgical approach without previous conization. In particular, immediate hysterectomy was more frequently performed on women aged ≥45 years compared to younger women (Table I). Overall, 143 women (93.5%) were diagnosed with stage IA1 cervical cancer and 10 women (6.5%) with stage IA2 cancer. Stromal infiltration was <1 mm in 101 cases (66%), ranged between 2 and 3 mm in 42 women (27.5%) and between 3 and 5 mm in 10 (6.5 %) cases. One hundred and forty-five (94.8%) were squamous carcinomas, 7 (4.6%) were adenocarcinomas whilst only one was adenosquamous carcinoma (0.6%). The median horizontal extension of cancer was 3 mm (range=2-7 mm); LVSI was reported in 5 cases (3.3%). Among the 132 women who underwent conization as primary surgery, 123 (93.2%) had disease at stage IA1 and 9 (6.8%) at stage IA2. Sixty-two stage IA1 women had conization as definitive surgery, because of free surgical margins and no LVSI; 61 underwent secondary surgery. Only 1 out of 9 stage IA2 carcinomas had conization as definitive surgery. Overall, 80 women (52.3%) were definitively treated with a conservative surgical approach during the study period, considering 63 women who underwent cervical conization as primary surgery, 16 women who had re-conization as secondary surgical treatment and one woman who underwent trachelectomy as a secondary approach. Pathological characteristics of primary cone excision and secondary surgical treatment of 69 women who underwent secondary surgery are reported in Table II. The mean interval to secondary surgery was 8±2.3 weeks while residual disease was found in 9 cases. All cases with residual disease had a diagnosis of stage IA1 at primary conization; the diagnosis Sopracordevole et al: Microinvasive Cervical Cancer Table II. Pathological characteristics of primary cone excision and secondary surgical treatment. Pathological characteristics of primary cone excision Secondary surgical treatment Conization Simple hysterectomy Radical hysterectomy Trachelectomy Total IA1 M– LVSI– M– LVSI+ M+ LVSI– M+ LVSI+ Total 11 0 4 1 16 34 0 3 0 37 3 0 3 0 6 0 1 0 0 1 48 1 10 1 60 IA2 M– LVSI– M– LVSI+ M+ LVSI– M+ LVSI+ Total 0 0 0 0 0 1 0 0 1 2 5 2 0 0 7 0 0 0 0 0 6 2 0 1 9 M: Cone margins; LVSI: lymph vascular space invasion. Table III. management of stage IA1 and stage IA2 cervical cancers with regard to histological features of the primary cone excision. Table IV. Correlation between the histological features of the primary cone excision and the risk of residual disease at secondary surgery. Residual disease M- LVSI- M- LVSI + M+ LVSI- M+ LVSI+ Total Stage IA1 Follow up Retreatment Residual disease Stage IA2 Follow up Retreatment Residual disease 61 48 4/48 1 1 0/1 0 10 5/10 0 1 0/1 62 60 9/60 1 6 0/6 0 2 0/2 0 0 0 0 1 0/1 1 9 0/9 Presence Absence Total M+ M– Total 5 4 9 7 53 60 12 57 69 LVSI+ LVSI– Total 0 9 9 5 55 60 5 64 69 M: Cone margins; LVSI: lymph vascular space invasion. M: Cone margins; LVSI: lymph vascular space invasion. of stage IA1 was confirmed in 8 out of 9 patients with residual disease, while 1 was re-staged IA2. The management of stage IA1 and IA2 cervical cancers, with regard to the histological features of the primary cone excision, is reported in Table III. Table IV reported the correlation between the histological characteristics of the primary cone excision and the residual disease at secondary surgery. After primary conization, 12 women had positive cone margins and 5 of them (41.7%) reported residual disease at secondary surgery. The rate of residual disease at secondary surgery in women with negative cone margins was 7%. No residual disease at secondary surgery in women with LVSI was reported and all cases of residual disease were LVSInegative at primary surgery. Residual disease was significantly related to positive surgical margins (41.7% vs. 7%, p=0.005) but not with LVSI on the cone excision (0 vs. 14.1%, p=0.83). In our series, surgical treatment progressively became more conservative. In the period between 1998-2003, 84 women were diagnosed with microinvasive cervical carcinoma; conization was the primary treatment in 79 patients (94%) while only 5 women had immediate hysterectomy. In the previous years, 69 women were diagnosed with microinvasive cervical carcinoma and conization was the primary treatment in 53 of them (76.8%): the rate of conservative surgery was significantly higher in the last years (94% vs. 76.8%, p=0.005). A ten-year followup was complete for each woman and no recurrence was found after a mean follow-up of 184.5±20.5 months. 4347 ANTICANCER RESEARCH 34: 4345-4350 (2014) Discussion This survey describes the surgical approach of microinvasive cervical cancer in four Gynecological Oncology Units in Northern Italy, during the period between 1993-2003. During the last decades, the incidence of microinvasive cervical cancer is increasing, mainly in young women aged less than 40 years and a high number of women are diagnosed with a cervical cancer before their first pregnancy. Different approaches are employed to treat microinvasive cervical cancer but a trend towards a conservative surgical approach has emerged, as preservation of fertility is desirable in young women and many studies reported the safety and efficacy of a fertility-sparing surgery, particularly in women with stage IA1 cervical cancer (4, 5, 15). Even in our experience, the surgical treatment of microinvasive cervical carcinoma progressively became more conservative and the rate of women treated with fertility-sparing surgery in the period 1998-2003 was significantly higher than the past years. The option of a fertility-sparing surgery appear to be clearly desirable in young women diagnosed with a microinvasive cervical cancer but some elements, such as the cone margins status with particular regard to the apex of the cone and also the LVSI must be taken into account because of a potential risk of residual disease and recurrence. The characteristics of the surgical margins should be accurately considered for deciding if conization could represent the definitive treatment for a patient with stage IA1 cervical cancer or if secondary surgery is appropriate. In our series, residual disease detected at secondary surgery was significantly related to positive surgical margins; multifocal disease probably accounted for the 4 cases of cancer identified on the specimen from secondary surgery, despite unaffected surgical margins and lack of LVSI on the primary cone excision. Lymph vascular space invasion represents one of the most controversial prognostic factors for microinvasive cervical cancer; previous studies reported a LVSI rate between 2.2% and 9.7% in patients with stage IA1 (14, 18, 19) and between 7.4% and 50% in stage IA2 (6, 20, 21). Nodal disease was noted in 8% of patients with LVSI compared to only 0.8% in patients without LVSI; likewise, a five-fold increased risk of recurrence in women with LVSI was reported (22). In our series, residual disease detected at secondary surgery was not related to LVSI on the primary cone excision. Our findings agree with those reported in a 2003 review by Creasman et al. (23) as most of the previous published studies suggest that LVSI does not represent an independent prognostic factor in women with microinvasive cervical carcinoma. However data are conflicting and other Authors have reported different results. Recently Raspagliesi et al. (24) and Costa et al. (25) reported that LVSI detected on the primary cone excision was significantly related to the risk of 4348 cancer relapse among stage IA1 patients, indicating that the debate on the prognostic value of LVSI is still open. Although published data are contradictory, the present survey did not find any correlation between LVSI on the primary cone excision and the risk of residual disease. However, in case of clear surgical margins and positive LVSI, the possibility of a pelvic lymph node sampling should be discussed with the patient. Even if the outcome of microinvasive cervical cancer is favorable, a close long-term surveillance should be scheduled for conservatively-treated women. One of the strengths of the present study is the long follow up period. The absence of recurrence or disease-related deaths in our cases after a mean follow-up of 184.5 months, once again confirms the efficacy and safety of conservative fertility-sparing surgery in women with microinvasive cervical cancer. Previous studies reported a risk of recurrence of less than 2% and a risk of death of only 0.1% in women with stage IA1 cervical cancer (12, 26). Burghardt et al. (26) analyzed a cohort of 344 patients with stage IA1 cervical cancer and noted only one (0.3%) recurrence that was diagnosed 12 years after treatment with conization. In a cohort of 494 patients with microinvasive cervical cancer treated by conization, Winter (27) noted four cancer-related deaths in patients with microinvasive disease after a mean follow-up of 14 years, without significant differences between stage IA1 and IA2. In conclusion, our study suggests that fertility-conserving surgery is efficacious and safe in women with IA1 cervical cancer with unaffected cone margins and independent of LVSI. A conservative surgical approach could also be considered in women with IA2 cervical cancer when preservation of fertility is strongly requested. It is the Authors' opinion that a close long-term surveillance should be scheduled for conservativelytreated women, and, in the absence of specific guidelines, at least 10 years of follow-up are required. Acknowledgements The authors would like to thank the following physicians for their important contribution: Alberto Agarossi, Giovanni De Piero, Laura Gallia, Vania Gardonio, Giorgio Giorda, Maria Teresa Mele, Gioia Montanari, Massimo Moscarini, Andrea Papadia and Patrizia Stentella. References 1 Costa S: Colposcopy and management of microinvasive squamous cell carcinoma. Minerva Ginecol 64(2): 121-136, 2012. 2 Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Sideri M and Pecorelli S: Carcinoma of the cervix uteri. J Epidemiol Biostat 6(1): 7-43, 2001. 3 Webb JC, Key CR, Qualls CR and Smith HO: Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 97(5): 701-706, 2001. Sopracordevole et al: Microinvasive Cervical Cancer 4 Gadducci A, Sartori E, Maggino T, Landoni F, Zola P, Cosio S, Pasinetti B, Alessi C, Maneo A and Ferrero A: The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study. Eur J Gynaecol Oncol 24(6): 513-516, 2003. 5 Wright JD, NathavithArana R, Lewin SN, Sun X, Deutsch I, Burke WM and Herzog TJ: Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 115(3): 585-590, 2010. 6 Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD and Homesley HD: Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol 178(1): 62-65, 1998. 7 Nam JH, Kim SH, Kim JH, Kim YM, Kim YT and Mok JE: Nonradical treatment is as effective as radical surgery in the management of cervical cancer stage IA1. Int J Gynecol Cancer 12(5): 480-484, 2002. 8 Steed H, Capstick V, Schepansky A, Honore L, Hiltz M and Faught W: Early cervical cancer and parametrial involvement: is it significant? Gynecol Oncol 103(1): 53-57, 2006. 9 Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W and Shaw P: How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 84(1): 145-149, 2002. 10 Plante M and Roy M: New approaches in the surgical management of early stage cervical cancer. Curr Opin Obstet Gynecol 13(1): 41-46, 2001. 11 Tseng CJ, Chang CC, Tseng CC, Hou HC, Wang CB, Chen CH, Soong YK and Pao CC: Loop conization for the treatment of microinvasive carcinoma of the cervix. Int J Gynecol Cancer 16(4): 1574-1578, 2006. 12 Lee SJ, Kim WY, Lee JW, Kim HS, Choi YL, Ahn GH, Lee JH, Kim BG and Bae DS: Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1 squamous cell carcinomas of the uterine cervix. Int J Gynecol Cancer 19(3): 407-411, 2009. 13 Hertel H, Köhler C, Grund D, Hillemanns P, Possover M, Michels W and Schneider A; German Association of Gynecologic Oncologists (AGO): Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol 103(2): 506-511, 2006. 14 Elliott P, Coppleson M, Russell P, Liouros P, Carter J, MacLeod C and Jones M: Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer 10(1): 42-52, 2000. 15 Benedet JL, Bender H, Jones H 3rd, Ngan HY and Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2): 209-262, 2000. 16 Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ and Bristow RE: Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 205(2): 103110, 2011. 17 Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2): 103104, 2009. 18 Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG and Roman LD: Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol 100(2): 288-293, 2006. 19 Lee KB, Lee JM, Park CY, Lee KB, Cho HY and Ha SY: Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer 16(3): 1184-1187, 2006. 20 Rogers LJ and Luesley DM: Stage IA2 cervical carcinoma: how much treatment is enough? Int J Gynecol Cancer 19(9): 16201624, 2009. 21 Kodama J, Mizutani Y, Hongo A, Yoshinouchi M, Kudo T and Okuda H: Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 101(2): 192-195, 2002. 22 Mota F: Microinvasive squamous carcinoma of the cervix: treatment modalities. Acta Obstet Gynecol Scand 82(6): 505509, 2003. 23 Creasman WT and Kohler MF: Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol 92(2): 525-529, 2004. 24 Raspagliesi F, Ditto A, Quattrone P, Solima E, Fontanelli R, Dousias V, Kusamura S and Carcangiu ML: Prognostic factors in microinvasive cervical squamous cell cancer: long-term results. Int J Gynecol Cancer 15: 88-93, 2005. 25 Costa S, Marra E, Martinelli GN, Santini D, Casadio P, Formelli G, Pelusi C, Ghi T, Syrjänen K and Pelusi G: Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer 19(1): 33-38, 2009. 26 Burghardt E, Girardi F, Lahousen M, Pickel H and Tamussino K: Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer. 67(4): 1037-1045, 1991. 27 Winter R: Conservative surgery for microinvasive carcinoma of the cervix. J Obstet Gynaecol Res 24(6): 433-436, 1998. Received April 9, 2014 Revised June 2, 2014 Accepted June 3, 2014 4349